Cargando…
Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary
BACKGROUND: Emerging data suggest that a treat-to-target approach and early therapeutic intervention using regular objective disease assessment leads to improved outcomes. Our aim was to evaluate the value of objective disease monitoring during regular follow-up in a single tertiary inflammatory bow...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish Society of Gastroenterology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334671/ https://www.ncbi.nlm.nih.gov/pubmed/36620930 http://dx.doi.org/10.5152/tjg.2023.22339 |
_version_ | 1785070909023846400 |
---|---|
author | Lontai, Livia Kürti, Zsuzsanna Gonczi, Lorant Komlódi, Nóra Balogh, Fruzsina Iliás, Ákos Lakatos, Peter L. |
author_facet | Lontai, Livia Kürti, Zsuzsanna Gonczi, Lorant Komlódi, Nóra Balogh, Fruzsina Iliás, Ákos Lakatos, Peter L. |
author_sort | Lontai, Livia |
collection | PubMed |
description | BACKGROUND: Emerging data suggest that a treat-to-target approach and early therapeutic intervention using regular objective disease assessment leads to improved outcomes. Our aim was to evaluate the value of objective disease monitoring during regular follow-up in a single tertiary inflammatory bowel disease center. METHODS: Consecutive inflammatory bowel disease patients (n = 161, Crohn’s disease: 118/ulcerative colitis: 43; biological therapy: 70%) were included and followed up for 1 year between January and December 2018. Data on clinical disease activity, biomarkers, endoscopy, imaging, outpatient visits, treatment optimization, hospitalization, and surgery were collected. We compared the monitoring strategy according to the clinical activity (remission/flare/post-flare/continuous activity) every 3 months (assessment period). RESULTS: In total, n = 644 assessment periods were evaluated. Biomarkers were evaluated in 82.9%-83.9% of patients in each assessment period regardless of clinical activity. Colonoscopy was more frequently performed in active disease (flare/continuous disease activity: 21.1%/18.9% vs. clinical remission: 10.1% per assessment period). Magnetic resonance imaging was performed in 7.7%-16.7%/period in Crohn’s disease patients, while the use of computed tomography was low (2.4%/period) and mainly performed in active disease. Treatment optimization was more frequent in patients with active disease (biological start/dose optimization: 31.1%/33.8%/period, steroid start: 13.2%/period). Patients with continuous activity (2.62), flare (2.45), and post-flare (2.05) had higher mean patient visit counts compared to remission (1.68/period). CONCLUSIONS: Objective monitoring strategy was applied with routine assessment of clinical activity and biomarkers. Fast-track colonoscopic evaluations were adapted to the clinical stage of the disease while screening colonoscopies and magnetic resonance imaging were frequently used. Objective monitoring resulted in the early optimization of medical therapy and frequent specialist follow-up visits. |
format | Online Article Text |
id | pubmed-10334671 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Turkish Society of Gastroenterology |
record_format | MEDLINE/PubMed |
spelling | pubmed-103346712023-07-12 Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary Lontai, Livia Kürti, Zsuzsanna Gonczi, Lorant Komlódi, Nóra Balogh, Fruzsina Iliás, Ákos Lakatos, Peter L. Turk J Gastroenterol Original Article BACKGROUND: Emerging data suggest that a treat-to-target approach and early therapeutic intervention using regular objective disease assessment leads to improved outcomes. Our aim was to evaluate the value of objective disease monitoring during regular follow-up in a single tertiary inflammatory bowel disease center. METHODS: Consecutive inflammatory bowel disease patients (n = 161, Crohn’s disease: 118/ulcerative colitis: 43; biological therapy: 70%) were included and followed up for 1 year between January and December 2018. Data on clinical disease activity, biomarkers, endoscopy, imaging, outpatient visits, treatment optimization, hospitalization, and surgery were collected. We compared the monitoring strategy according to the clinical activity (remission/flare/post-flare/continuous activity) every 3 months (assessment period). RESULTS: In total, n = 644 assessment periods were evaluated. Biomarkers were evaluated in 82.9%-83.9% of patients in each assessment period regardless of clinical activity. Colonoscopy was more frequently performed in active disease (flare/continuous disease activity: 21.1%/18.9% vs. clinical remission: 10.1% per assessment period). Magnetic resonance imaging was performed in 7.7%-16.7%/period in Crohn’s disease patients, while the use of computed tomography was low (2.4%/period) and mainly performed in active disease. Treatment optimization was more frequent in patients with active disease (biological start/dose optimization: 31.1%/33.8%/period, steroid start: 13.2%/period). Patients with continuous activity (2.62), flare (2.45), and post-flare (2.05) had higher mean patient visit counts compared to remission (1.68/period). CONCLUSIONS: Objective monitoring strategy was applied with routine assessment of clinical activity and biomarkers. Fast-track colonoscopic evaluations were adapted to the clinical stage of the disease while screening colonoscopies and magnetic resonance imaging were frequently used. Objective monitoring resulted in the early optimization of medical therapy and frequent specialist follow-up visits. Turkish Society of Gastroenterology 2023-05-01 /pmc/articles/PMC10334671/ /pubmed/36620930 http://dx.doi.org/10.5152/tjg.2023.22339 Text en © 2023 authors https://creativecommons.org/licenses/by/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Original Article Lontai, Livia Kürti, Zsuzsanna Gonczi, Lorant Komlódi, Nóra Balogh, Fruzsina Iliás, Ákos Lakatos, Peter L. Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary |
title | Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary |
title_full | Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary |
title_fullStr | Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary |
title_full_unstemmed | Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary |
title_short | Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary |
title_sort | objective disease monitoring strategies from a tertiary inflammatory bowel disease center in hungary |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334671/ https://www.ncbi.nlm.nih.gov/pubmed/36620930 http://dx.doi.org/10.5152/tjg.2023.22339 |
work_keys_str_mv | AT lontailivia objectivediseasemonitoringstrategiesfromatertiaryinflammatoryboweldiseasecenterinhungary AT kurtizsuzsanna objectivediseasemonitoringstrategiesfromatertiaryinflammatoryboweldiseasecenterinhungary AT gonczilorant objectivediseasemonitoringstrategiesfromatertiaryinflammatoryboweldiseasecenterinhungary AT komlodinora objectivediseasemonitoringstrategiesfromatertiaryinflammatoryboweldiseasecenterinhungary AT baloghfruzsina objectivediseasemonitoringstrategiesfromatertiaryinflammatoryboweldiseasecenterinhungary AT iliasakos objectivediseasemonitoringstrategiesfromatertiaryinflammatoryboweldiseasecenterinhungary AT lakatospeterl objectivediseasemonitoringstrategiesfromatertiaryinflammatoryboweldiseasecenterinhungary |